• Subscribe
  • Magazine
  • Videos
  • Advertise
  • About Us
  • Smart Water Summit
  • Wastewater Summit
    • Recent Quotes
    My Watchlist
    Indicators
    WaterWorld Market Index
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    Latest News about BIOVF

    Recent news which mentions BIOVF

    Merck Virus Treatment Shows 60.4% Effectiveness, Reduces Certain Infections In Infants
    Tickers BIOVF MRK NEWS
    Tags General pharmacy BIOVF
    From Benzinga
    Apellis Pharmaceuticals' Pegcetacoplan Meets Primary Goal In Late-Stage Study In Patients With Rare Kidney Diseases
    Tickers APLS BIOVF NEWS SWOBY
    Tags Stories That Matter why it's moving General
    From Benzinga
    Pfizer, Sanofi's Respiratory Syncytial Virus Products Faces Insurance And Logistical Hurdles To Protect Infants
    Tickers AZN BIOVF PFE SNY
    Tags Biotech Market News PFE
    From Benzinga
    Unanimous Support for AstraZeneca and Sanofi's Nirsevimab: Next Generation RSV Treatment on the Horizon
    Tickers AZN AZNCF BIOVF SNY
    Tags Biotech Market News Briefs
    From Benzinga
    Apellis Pharma Flunks On Primary, Secondary Endpoints In Amyotrophic Lateral Sclerosis Study
    Tickers APLS BIOVF
    Tags Health Care Markets News
    From Benzinga
    Benzinga's 'Stock Whisper' Index: 5 Stocks Investors Are Secretly Monitoring But Not Talking About Yet
    Tickers ABNB BIOVF CTIC PACW
    Tags Penny Stocks Stocks To Watch Exclusives
    From Benzinga
    Why Shares of CTI BioPharma Are Soaring Wednesday
    Tickers BIOVF CTIC
    Tags CTIC BIOVF Recent Press Releases
    From Motley Fool
    European Swedish Orphan Biovitrum To Acquire CTI BioPharma For $1.7B
    Tickers BIOVF CTIC
    Tags Health Care Penny Stocks News
    From Benzinga
    Selecta, SOBI's Chronic Refractory Gout Program Meets Primary Goal, US Submission Expected Next Year
    Tickers BIOVF SELB
    Tags Biotech Market News Movers
    From Benzinga
    Veru Stock Could Retrace Week's 45% Gain As FDA Panel Votes Against COVID-19 Drug
    Tickers BIOVF VERU
    Tags Sabizabulin News clinical trial
    From Benzinga
    Europe Approves AstraZeneca-Sanofi Partnered Antibody To Prevent RSV Infection In Infants
    Tickers AZN AZNCF BIOVF SNY
    Tags Eurasia AZN SNY
    From Benzinga
    Sanofi's Hemophilia Candidate Goes Under Priority FDA Review
    Tickers BIOVF SNY
    Tags News Large Cap Health Care
    From Benzinga
    The Daily Biotech Pulse: Europe Approves Second Round Of Booster Doses of mRNA COVID-19 Vaccines, Perrigo Seeks Approval For First OTC Birth Control Pill, MacroGenics Closes Head & Cancer Study After
    Tickers BIOVF CANF IBB INVA
    Tags M&A BIOVF SNY
    From Benzinga
    SOBI-Sanofi Partnered Hemophilia Therapy Shows Superior Bleed Protection Than Prior Prophylaxis
    Tickers BIOVF SNY
    Tags Health Care News Briefs
    From Benzinga
    The Daily Biotech Pulse: Pfizer Inks Pact With Africa For COVID-19 Pills, Emergent Bio & Ridgeback To Increase Access To Ebola Treatment, ADC Therapeutics & Sobi In European Pact For Lymphoma Drug
    Tickers ADCT ANNX ATHX BIOVF
    Tags Large Cap Penny Stocks Health Care
    From Benzinga
    ADC Therapeutics, Sobi Ink European Licensing Pact For Lymphoma Drug
    Tickers ADCT BIOVF
    Tags News Health Care Market News
    From Benzinga
    Sanofi-SOBI Hemophilia Candidate Aces Late-Stage Study In Pretreated Patients
    Tickers BIOVF SNY
    Tags Trading Ideas Hemophilia A Phase 3 Results
    From Benzinga
    Apellis - Sobi's Pegcetacoplan Wins European Approval For Rare Blood Disorder
    Tickers APLS BIOVF
    Tags BIOVF Benzinga Briefs
    From Benzinga
    AstraZeneca Blocks SOBI's $8B Buyout, Advent Withdraws The Bid - Report
    Tickers AZN AZNCF BIOVF
    Tags News AZNCF AZN
    From Benzinga
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.